Plain-English translation of NCT05278715 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a modified and chemotherapy regimen for children and young adults with optic pathway gliomas — tumors that grow along the nerves controlling vision. The researchers have already shown in a small group of patients that this modified version of the treatment may help stop tumor growth faster and improve vision better than standard chemotherapy. This trial aims to confirm those promising early results in a larger group of patients.
Optic pathway gliomas can cause vision loss, and while chemotherapy is often used to stop these tumors from growing, standard treatments don't always preserve or improve eyesight and can take a long time to work. This medication was designed to work faster and protect vision better, and this trial is testing whether it truly does.
You likely qualify if…
You likely don't qualify if…
You would receive the modified chemotherapy treatment, likely as an outpatient (visiting the hospital for appointments). You would need regular MRI scans to monitor the tumor and frequent vision tests (including eye exams and special tests to measure how well your eyes are working) to track any changes in your sight. The study involves close follow-up with both oncology and eye specialists to make sure the treatment is working and to watch for any side effects.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
China